News

DelCorean’s Cramp 911 provides fast-acting muscle relief

BY Michael Johnsen

COOPERSBURG, Pa. DelCorean launched its homeopathic Cramp 911 fast-acting topical muscle relaxer at ECRM Health Care in Miami, marking a potential new indication for topical analgesic shelves.

According to the company, muscle cramps impact people across a broad spectrum of activity and age. As many as 18 million seniors in the United States suffer from chronic muscle cramps, the company noted, and 10% of users of prescription statins suffer from statin-induced muscle cramps as a side effect. The product also may be used by patients with fibromyalgia who suffer from chronic muscle pain due to constant muscle contraction.

When Cramp 911 is applied directly to the affected area, the product offers rapid relief usually within one to two minutes without the return of the cramp/spasm.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
News

Stiefel zaps acne segment with ‘leave-on’ treatment

BY Michael Johnsen

DULUTH, Ga. Stiefel Labs, a GlaxoSmithKline company, launched one of the first “leave-on” treatments for acne care, PanOxyl, as a line extension to the company’s acne-care bar and wash.

The formulation is not greasy as compared with spot treatments, and blends into the skin upon application. The new formulation delivers 10% Benzoyl Peroxide in a foam delivery.

In addition to consumer ad support, Stiefel will be fielding its 200-strong dedicated representatives to detail dermatologists.

Stiefel also introduced its Sensitive Sarna eczema itch relief kit, an all-in-one kit that includes a cleanse, itch relief and moisturizer.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
News

New directors elected to NACDS Foundation board

BY Drug Store News Team

ALEXANDRIA, Va. The National Association of Chain Drug Stores has elected three new directors to the board of the NACDS Foundation.

Jim VanLieshout, VP retail sales with Apotex; Alice Swearingen, VP channel development sales for GlaxoSmithKline; and Chris Dimos, president of pharmacy operations for Supervalu, will fill vacancies on the board, which consists of 22 members. 

“We are pleased to welcome the three new members to the NACDS Foundation board of directors,” said Edith Rosato, president of the NACDS Foundation.

“They will continue the strong representation on the board of chains and suppliers alike. We value their expertise, dedication and commitment to the industry, and we look forward to working together for the good of the public and the patients served by community pharmacy.”

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?